Chemo-immunotherapy approach shows potential benefit in patients with advanced HPV-negative head and neck cancer
Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...
CURE53m
What the FDA Approval of Bizengri Means for Patients With NRG1-Positive NSCLC
The FDA granted its first approval for a systemic therapy for patients with non-small cell lung cancer with an Neuregulin 1 ...
CURE53m
FDA Approval of Ensacove Adds to the Toolkit for ALK-Positive NSCLC
An expert explained the importance of the FDA’s approval of Ensacove for patients with ALK-positive non-small cell lung ...
Northwell Radiation Centers Introduce Varian Ethos HyperSight To LI
The advanced radiation therapy offers cancer patients quick, targeted treatments in one facility. The centers are the first ...
NIH cuts could have 'negative consequences' for Long Island economy, says business group's letter to New York Congressional delegation
Local economies depend on grant recipients, the letter said, "to conduct critical research that drives industry innovation." ...